TipRanks
Resmed (GB:0KW4)
LSE:0KW4
UK Market
0KW4
Resmed
RESEARCH TOOLSreports

Resmed (0KW4) Ratios

0 Followers

Resmed Ratios

GB:0KW4's free cash flow for Q1 2027 was $0.62. For the 2027 fiscal year, GB:0KW4's free cash flow was decreased by $ and operating cash flow was $0.38. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 2.65 3.10 3.44 2.59 3.12
Quick Ratio
 1.88 2.42 2.53 1.69 1.81
Cash Ratio
 0.76 1.05 1.19 0.26 0.30
Solvency Ratio
 0.80 0.74 0.74 0.62 0.42
Operating Cash Flow Ratio
 2.36 1.29 1.72 1.54 0.91
Short-Term Operating Cash Flow Coverage
 19.52 6.95 176.93 141.54 70.02
Net Current Asset Value
$ 1.24B$ 1.94B$ 1.30B$ 349.37M$ -253.97M
Leverage Ratios
Debt-to-Assets Ratio
 0.07 0.09 0.10 0.13 0.23
Debt-to-Equity Ratio
 0.10 0.13 0.14 0.18 0.38
Debt-to-Capital Ratio
 0.09 0.11 0.12 0.15 0.28
Long-Term Debt-to-Capital Ratio
 0.04 0.06 0.10 0.13 0.26
Financial Leverage Ratio
 1.38 1.36 1.37 1.41 1.63
Debt Service Coverage Ratio
 9.84 6.76 72.71 23.19 20.16
Interest Coverage Ratio
 75.81 0.00 133.66 28.88 23.89
Debt to Market Cap
 0.01 0.02 0.02 0.03 0.04
Interest Debt Per Share
 4.45 5.71 5.89 6.26 11.09
Net Debt to EBITDA
 -0.18 -0.30 -0.19 0.41 1.00
Profitability Margins
Gross Profit Margin
61.18%61.06%59.36%56.67%55.78%
EBIT Margin
35.09%33.76%32.60%27.97%27.52%
EBITDA Margin
39.07%38.08%37.18%32.73%32.18%
Operating Profit Margin
33.13%33.76%32.75%28.17%26.80%
Pretax Profit Margin
35.09%33.95%32.60%27.00%26.09%
Net Profit Margin
27.79%26.94%27.22%21.79%21.25%
Continuous Operations Profit Margin
27.79%26.94%27.22%21.79%21.25%
Net Income Per EBT
79.19%79.36%83.50%80.72%81.47%
EBT Per EBIT
105.93%100.57%99.54%95.83%97.33%
Return on Assets (ROA)
19.40%16.99%17.14%14.86%13.29%
Return on Equity (ROE)
25.14%23.13%23.47%20.99%21.73%
Return on Capital Employed (ROCE)
27.57%25.21%23.55%22.14%18.89%
Return on Invested Capital (ROIC)
21.24%19.27%19.56%17.77%15.31%
Return on Tangible Assets
32.78%27.18%30.04%28.80%26.17%
Earnings Yield
4.85%5.40%3.70%3.71%2.80%
Efficiency Ratios
Receivables Turnover
 5.89 5.46 5.19 5.60 5.99
Payables Turnover
 6.94 7.13 7.52 8.54 12.39
Inventory Turnover
 2.18 2.33 2.25 2.47 1.87
Fixed Asset Turnover
 7.18 7.69 7.16 6.70 6.34
Asset Turnover
 0.70 0.63 0.63 0.68 0.63
Working Capital Turnover Ratio
 2.24 2.09 2.62 3.07 2.96
Cash Conversion Cycle
 176.85 172.48 183.63 170.33 226.54
Days of Sales Outstanding
 61.92 66.90 70.26 65.23 60.93
Days of Inventory Outstanding
 167.53 156.80 161.91 147.84 195.08
Days of Payables Outstanding
 52.60 51.21 48.55 42.74 29.47
Operating Cycle
 229.45 223.70 232.17 213.07 256.00
Cash Flow Ratios
Operating Cash Flow Per Share
 21.83 12.48 11.94 9.53 4.72
Free Cash Flow Per Share
 19.92 11.40 11.33 8.75 3.81
CapEx Per Share
 1.91 1.08 0.61 0.78 0.91
Free Cash Flow to Operating Cash Flow
 0.91 0.91 0.95 0.92 0.81
Dividend Paid and CapEx Coverage Ratio
 3.50 3.57 4.37 3.53 1.77
Capital Expenditure Coverage Ratio
 11.43 11.55 19.49 12.20 5.17
Operating Cash Flow Coverage Ratio
 5.11 2.19 2.06 1.60 0.44
Operating Cash Flow to Sales Ratio
 0.54 0.32 0.34 0.30 0.16
Free Cash Flow Yield
8.81%5.85%4.39%4.68%1.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 20.92 18.67 27.02 26.92 35.73
Price-to-Sales (P/S) Ratio
 5.64 4.99 7.36 5.87 7.59
Price-to-Book (P/B) Ratio
 5.53 4.28 6.34 5.65 7.76
Price-to-Free Cash Flow (P/FCF) Ratio
 11.35 17.10 22.78 21.37 57.34
Price-to-Operating Cash Flow Ratio
 10.53 15.62 21.61 19.61 46.25
Price-to-Earnings Growth (PEG) Ratio
 1.74 2.00 0.72 2.01 2.45
Enterprise Value Multiple
 14.26 12.80 19.60 18.34 24.60
Enterprise Value
 31.94B 27.56B 37.50B 28.12B 33.42B
EV to EBITDA
 14.26 12.80 19.60 18.34 24.60
EV to Sales
 5.57 4.87 7.29 6.00 7.91
EV to Free Cash Flow
 11.21 16.71 22.56 21.86 59.75
EV to Operating Cash Flow
 10.23 15.26 21.41 20.07 48.20
Tangible Book Value Per Share
 18.16 22.27 16.74 10.45 5.50
Shareholders’ Equity Per Share
 41.60 45.51 40.68 33.08 28.14
Tax and Other Ratios
Effective Tax Rate
 0.21 0.21 0.17 0.19 0.19
Revenue Per Share
 40.09 39.07 35.08 31.87 28.77
Net Income Per Share
 11.14 10.53 9.55 6.94 6.12
Tax Burden
 0.79 0.79 0.83 0.81 0.81
Interest Burden
 1.00 1.01 1.00 0.97 0.95
Research & Development to Revenue
 0.07 0.07 0.06 0.07 0.07
SG&A to Revenue
 0.20 0.20 0.19 0.00 0.00
Stock-Based Compensation to Revenue
 0.03 0.02 0.02 0.02 0.02
Income Quality
 1.14 1.19 1.25 1.37 0.77
Currency in USD